You just read:

Mallinckrodt Analysis Suggests Acthar® Gel (Repository Corticotropin Injection) May be a Cost-Effective Option Compared to Other Late-Line, Adult Treatments for Multiple Sclerosis Relapse

News provided by

Mallinckrodt plc

Sep 13, 2019, 06:45 ET